Secondly, although GCN2 appears to have a driving role in a number of different types of cancer, such as ovarian cancer, leukaemia, glioblastoma and MM, but this appears to only be of consequence under certain mutational backgrounds. This evidence concerns the gene EIF2AK4 and leukemia.